What is the brand name of a topical cream suitable for treating mild plaque psoriasis in an adult?

Brand Name Topical Creams for Mild Psoriasis

For mild plaque psoriasis in adults, I recommend starting with a combination product containing calcipotriene and betamethasone dipropionate, available as Enstilar® (foam), Taclonex® (ointment/suspension), or the newer cream formulations. These combination products represent the highest level of evidence (Grade A recommendation) for topical psoriasis treatment 1.

Primary Treatment Options

First-Line: Calcipotriene/Betamethasone Combination Products

The 2021 AAD-NPF guidelines strongly recommend (Grade A) combination products with calcipotriene (vitamin D analogue) and corticosteroids for mild to moderate psoriasis 1. These combinations are:

• More effective than either agent alone when used for 3-52 weeks
• In a 52-week study of 828 patients, 69-74% achieved clear or almost clear skin versus only 27% with vehicle control (P < .001) 1
• No serious adverse events including striae or adrenal suppression were observed over 52 weeks of treatment 1

Brand names include:

• Enstilar® (foam formulation)
• Taclonex® (ointment/suspension)
• Generic calcipotriene 0.005%/betamethasone dipropionate 0.064% cream

The cream formulation specifically offers high patient satisfaction and adherence due to favorable cosmetic characteristics 2.

Alternative First-Line: Tapinarof Cream

VTAMA® (tapinarof 1% cream) is a newer FDA-approved, non-steroidal option that represents a paradigm shift in topical psoriasis treatment 3, 4:

• Applied once daily (more convenient than twice-daily regimens)
• In phase 3 trials, 35.4-40.2% of patients achieved clear/almost clear skin at 12 weeks versus 6.0-6.3% with vehicle 4
• 40.9% achieved complete clearance (PGA = 0) during treatment 3
• Maintains disease clearance for approximately 4 months after stopping treatment 3, 5
• Non-steroidal mechanism (aryl hydrocarbon receptor agonist), avoiding corticosteroid-related concerns 5

Common pitfall: Tapinarof can cause folliculitis and contact dermatitis at application sites, though these are generally mild to moderate and have low discontinuation rates 3.

Treatment Algorithm

For initial therapy:

1. Start with calcipotriene/betamethasone combination (Enstilar®, Taclonex®, or generic cream) - strongest evidence base, proven long-term safety
2. Consider tapinarof (VTAMA®) if patient prefers once-daily application, wants steroid-free option, or needs extended remission after treatment

Application strategies for combination products (Grade B recommendations) 1:

• Weekday/weekend regimen: Vitamin D analogue twice daily on weekdays + high-potency corticosteroid twice daily on weekends for maintenance
• Morning/evening regimen: High-potency corticosteroid in morning + vitamin D analogue in evening

Important Caveats

Avoid these combinations:

• Do not use salicylic acid with calcipotriene - the acidic pH inactivates calcipotriene and reduces effectiveness 1
• Apply vitamin D analogues AFTER phototherapy if combining treatments, not before, to avoid UV inactivation 1

For specific body areas:

• Scalp: Calcipotriene foam or calcipotriene/betamethasone gel for 4-12 weeks (Grade A) 1
• Face: Calcipotriene combined with hydrocortisone (lower potency steroid) for 8 weeks (Grade B) 1

The cream formulations enhance adherence compared to ointments due to better cosmetic acceptability, which directly impacts treatment success 2.